{"id":3878,"date":"2017-03-15T18:41:56","date_gmt":"2017-03-15T18:41:56","guid":{"rendered":"https:\/\/lpfch.org\/fibrolamellar-cancer-foundation-visits-dr-sage\/"},"modified":"2024-02-16T20:55:20","modified_gmt":"2024-02-16T20:55:20","slug":"fibrolamellar-cancer-foundation-visits-dr-sage","status":"publish","type":"post","link":"http:\/\/lpfch.org\/es\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/","title":{"rendered":"La Fundaci\u00f3n del C\u00e1ncer Fibrolamelar visita al Dr. Sage"},"content":{"rendered":"<p>Justo antes de cumplir 27 a\u00f1os, a Tucker Davis le diagnosticaron carcinoma hepatocelular fibrolamelar (CHC-FL). El CHC-FL es un c\u00e1ncer de h\u00edgado poco com\u00fan que suele presentarse en adolescentes y adultos j\u00f3venes sin antecedentes de enfermedad hep\u00e1tica. El CHC-FL tiene una tasa de incidencia de 1 por cada 5 millones en la poblaci\u00f3n general. Los c\u00e1nceres ultrarraros se definen como aquellos con menos de 1000 casos al a\u00f1o; el CHC-FL se diagnostica en aproximadamente 200 a 300 pacientes cada a\u00f1o en Estados Unidos.<\/p>\n<p>Poco despu\u00e9s de ser diagnosticado, Tucker, junto con tres amigos, Alisha Sternenberger, Charles Beermann y Derek Gilchrist, fund\u00f3 la <a href=\"https:\/\/fibrofoundation.org\/\">Fundaci\u00f3n del C\u00e1ncer Fibrolamelar<\/a> (FCF). La misi\u00f3n de FCF es encontrar una cura y opciones de tratamiento para el carcinoma hepatocelular cong\u00e9nito (CHC-FL), concientizar sobre la enfermedad y conectar y apoyar a la comunidad de pacientes y familias con CHC-FL. Desde su fundaci\u00f3n en 2009, FCF ha invertido aproximadamente entre 1 y 6 millones de d\u00f3lares en investigaci\u00f3n.<\/p>\n<p>Para ayudar a encontrar una cura y nuevas opciones de tratamiento para el FL-HCC, FCF financia investigaciones en instituciones de clase mundial, incluida la Facultad de Medicina de la Universidad de Stanford. <a href=\"https:\/\/profiles.stanford.edu\/julien-sage\">Julien Sage, doctor<\/a>El Dr. Sage, profesor de Hematolog\u00eda\/Oncolog\u00eda y Gen\u00e9tica Pedi\u00e1trica, recibi\u00f3 una beca de dos a\u00f1os ($292,242) de la FCF para desarrollar un modelo murino precl\u00ednico de carcinoma hepatocelular de c\u00e9lulas grandes (CHC-FL). Los ensayos cl\u00ednicos para el CHC-FL se ven limitados por ser una enfermedad poco frecuente, que se presenta principalmente en adolescentes y adultos j\u00f3venes. El desarrollo de modelos precl\u00ednicos precisos es fundamental para desarrollar mejores terapias para pacientes con CHC-FL. Estos modelos pueden utilizarse para investigar los mecanismos b\u00e1sicos del desarrollo del CHC-FL, identificar potencialmente nuevas dianas terap\u00e9uticas y probar estrategias terap\u00e9uticas novedosas. Si bien el CHC-FL es un c\u00e1ncer extremadamente raro, la esperanza del Dr. Sage y la FCF es que parte de lo aprendido en la investigaci\u00f3n sobre el CHC-FL pueda aplicarse a otros tipos de c\u00e1ncer. Como explica el Dr. Sage: \u00abMi inter\u00e9s inicial en el CHC-FL surgi\u00f3 de mi trabajo previo en c\u00e1nceres pedi\u00e1tricos poco frecuentes, como el retinoblastoma. Muchos de estos tumores poco frecuentes pueden ense\u00f1arnos mucho sobre los mecanismos fundamentales de la tumorig\u00e9nesis\u00bb.<\/p>\n<p>Tras el primer a\u00f1o de la subvenci\u00f3n, el director ejecutivo de FCF, John Hopper, y el miembro de la junta directiva, John Craig, MD, PhD, visitaron al Dr. Sage y su laboratorio para conocer mejor el progreso del proyecto. El Dr. Craig, pat\u00f3logo responsable de nombrar el FL-HCC, tambi\u00e9n lidera el Comit\u00e9 de Revisi\u00f3n de Subvenciones de FCF. La Dra. Pam Craig, MD, PhD, esposa del Dr. John Craig, tambi\u00e9n asisti\u00f3 a la reuni\u00f3n con el Dr. Sage. El equipo de FCF realiz\u00f3 un recorrido por el laboratorio del Dr. Sage y luego escuch\u00f3 una presentaci\u00f3n de Garry Coles, PhD, investigador postdoctoral en el laboratorio del Dr. Sage. El Dr. Coles comparti\u00f3 los resultados de los esfuerzos del equipo para desarrollar cepas de ratones con una alteraci\u00f3n gen\u00e9tica distintiva que resulta en la fusi\u00f3n de dos prote\u00ednas, DnaJB1 y PKA. Se ha descubierto que esta fusi\u00f3n est\u00e1 presente en todos los tumores FL-HCC secuenciados hasta ahora, incluyendo pacientes secuenciados en Stanford como una colaboraci\u00f3n entre el equipo del Dr. Sage, el Dr. Arun Rangaswami (onc\u00f3logo cl\u00ednico en el Lucile Packard Children&#039;s Hospital Stanford), la Dra. Florette Hazard (pat\u00f3loga en el Stanford University Medical Center) y el Dr. Michael Snyder (director del Center for Genomics and Personalized Medicine en la Stanford University). Si la prote\u00edna de fusi\u00f3n causa tumores en las cepas de ratones que el Dr. Sage y el Dr. Coles est\u00e1n desarrollando, demostrar\u00e1 de manera concluyente que su expresi\u00f3n es un paso esencial en el crecimiento del tumor FL-HCC y proporcionar\u00e1 nuevos conocimientos sobre el desarrollo del FL-HCC. La generaci\u00f3n de ratones que desarrollen tumores FL-HCC que se asemejen a los tumores humanos proporcionar\u00eda una valiosa plataforma precl\u00ednica para probar nuevas terapias. &quot;El trabajo de investigaci\u00f3n del impresionante equipo del Dr. Sage es fundamental para acelerar el camino hacia terapias curativas para pacientes fibrolamelares&quot;, se\u00f1ala John Hopper de FCF. \u201cComo parte importante de la comunidad FCF, el enfoque \u00fanico de Stanford desempe\u00f1ar\u00e1 un papel fundamental a corto y largo plazo tanto en la investigaci\u00f3n b\u00e1sica como en la traslacional\u201d.<\/p>\n<p>La investigaci\u00f3n de la Facultad de Medicina de Stanford se encuentra a la vanguardia gracias al enfoque colaborativo e interdisciplinario de su profesorado para resolver los problemas m\u00e1s complejos del mundo. &quot;Stanford es un lugar \u00fanico para estudiar enfermedades como el carcinoma hepatocelular de c\u00e9lulas peque\u00f1as (CHC-FL), con un destacado grupo de m\u00e9dicos dedicados al tratamiento de ni\u00f1os con c\u00e1ncer de h\u00edgado y tecnolog\u00edas \u00fanicas para investigar la biolog\u00eda de las c\u00e9lulas cancerosas del h\u00edgado, incluyendo enfoques avanzados de gen\u00e9tica, gen\u00f3mica y prote\u00f3mica&quot;, explic\u00f3 el Dr. Sage. &quot;Siempre me han interesado las enfermedades pedi\u00e1tricas y del desarrollo, y creo que la Universidad de Stanford es una comunidad cient\u00edfica incre\u00edble y colaborativa, un entorno ideal para plantear preguntas sobre el origen de enfermedades como el CHC-FL&quot;, a\u00f1adi\u00f3 el Dr. Coles.<\/p>\n<p>Adem\u00e1s de estar feliz de estudiar con un mentor tan experimentado como el Dr. Sage, el Dr. Coles tambi\u00e9n se muestra optimista sobre su investigaci\u00f3n sobre el carcinoma hepatocelular de c\u00e9lulas peque\u00f1as (CHC-FL): \u00abEstoy entusiasmado de realizar mi formaci\u00f3n posdoctoral en la Universidad de Stanford bajo la tutela del Dr. Sage. Creo que nuestro trabajo mejorar\u00e1 nuestra comprensi\u00f3n de la biolog\u00eda del CHC-FL y proporcionar\u00e1 informaci\u00f3n para el dise\u00f1o de futuras terapias\u00bb.<\/p>","protected":false},"excerpt":{"rendered":"<p>Justo antes de cumplir 27 a\u00f1os, a Tucker Davis le diagnosticaron carcinoma hepatocelular fibrolamelar (CHC-FL). El CHC-FL es un c\u00e1ncer de h\u00edgado poco com\u00fan que suele presentarse en adolescentes\u2026<\/p>","protected":false},"author":17,"featured_media":14826,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[21],"class_list":["post-3878","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-donor-stories","health_topic-pediatric-cancer","engagement_type-foundation-giving"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Fibrolamellar Cancer Foundation Visits Dr. Sage - Lucile Packard Foundation for Children&#039;s Health<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/lpfch.org\/es\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fibrolamellar Cancer Foundation Visits Dr. Sage\" \/>\n<meta property=\"og:description\" content=\"Just before he turned 27, Tucker Davis was diagnosed with fibrolamellar hepatocellular carcinoma (FL-HCC). FL-HCC is a rare liver cancer that usually occurs in adolescents...\" \/>\n<meta property=\"og:url\" content=\"http:\/\/lpfch.org\/es\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\" \/>\n<meta property=\"og:site_name\" content=\"Lucile Packard Foundation for Children&#039;s Health\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-15T18:41:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-16T20:55:20+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"522\" \/>\n\t<meta property=\"og:image:height\" content=\"280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c\"},\"headline\":\"Fibrolamellar Cancer Foundation Visits Dr. Sage\",\"datePublished\":\"2017-03-15T18:41:56+00:00\",\"dateModified\":\"2024-02-16T20:55:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\"},\"wordCount\":805,\"commentCount\":0,\"image\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg\",\"articleSection\":[\"Donor Stories\"],\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\",\"url\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\",\"name\":\"Fibrolamellar Cancer Foundation Visits Dr. Sage - Lucile Packard Foundation for Children&#039;s Health\",\"isPartOf\":{\"@id\":\"https:\/\/lpfch.org\/km\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg\",\"datePublished\":\"2017-03-15T18:41:56+00:00\",\"dateModified\":\"2024-02-16T20:55:20+00:00\",\"author\":{\"@id\":\"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c\"},\"breadcrumb\":{\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage\",\"url\":\"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg\",\"contentUrl\":\"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg\",\"width\":522,\"height\":280},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lpfch.org\/hy\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fibrolamellar Cancer&hellip;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lpfch.org\/km\/#website\",\"url\":\"https:\/\/lpfch.org\/km\/\",\"name\":\"Lucile Packard Foundation for Children&#039;s Health\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lpfch.org\/km\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/lpfch.org\/wp\"],\"url\":\"http:\/\/lpfch.org\/es\/impact-stories\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fibrolamellar Cancer Foundation Visits Dr. Sage - Lucile Packard Foundation for Children&#039;s Health","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/lpfch.org\/es\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/","og_locale":"es_ES","og_type":"article","og_title":"Fibrolamellar Cancer Foundation Visits Dr. Sage","og_description":"Just before he turned 27, Tucker Davis was diagnosed with fibrolamellar hepatocellular carcinoma (FL-HCC). FL-HCC is a rare liver cancer that usually occurs in adolescents...","og_url":"http:\/\/lpfch.org\/es\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/","og_site_name":"Lucile Packard Foundation for Children&#039;s Health","article_published_time":"2017-03-15T18:41:56+00:00","article_modified_time":"2024-02-16T20:55:20+00:00","og_image":[{"width":522,"height":280,"url":"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#article","isPartOf":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/"},"author":{"name":"admin","@id":"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c"},"headline":"Fibrolamellar Cancer Foundation Visits Dr. Sage","datePublished":"2017-03-15T18:41:56+00:00","dateModified":"2024-02-16T20:55:20+00:00","mainEntityOfPage":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/"},"wordCount":805,"commentCount":0,"image":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage"},"thumbnailUrl":"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg","articleSection":["Donor Stories"],"inLanguage":"es-ES","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#respond"]}]},{"@type":"WebPage","@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/","url":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/","name":"Fibrolamellar Cancer Foundation Visits Dr. Sage - Lucile Packard Foundation for Children&#039;s Health","isPartOf":{"@id":"https:\/\/lpfch.org\/km\/#website"},"primaryImageOfPage":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage"},"image":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage"},"thumbnailUrl":"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg","datePublished":"2017-03-15T18:41:56+00:00","dateModified":"2024-02-16T20:55:20+00:00","author":{"@id":"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c"},"breadcrumb":{"@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#primaryimage","url":"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg","contentUrl":"http:\/\/lpfch.org\/wp-content\/uploads\/2024\/02\/2_1.jpg","width":522,"height":280},{"@type":"BreadcrumbList","@id":"http:\/\/lpfch.org\/ko\/impact-stories\/fibrolamellar-cancer-foundation-visits-dr-sage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lpfch.org\/hy\/"},{"@type":"ListItem","position":2,"name":"Fibrolamellar Cancer&hellip;"}]},{"@type":"WebSite","@id":"https:\/\/lpfch.org\/km\/#website","url":"https:\/\/lpfch.org\/km\/","name":"Fundaci\u00f3n Lucile Packard para la Salud Infantil","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lpfch.org\/km\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Person","@id":"https:\/\/lpfch.org\/km\/#\/schema\/person\/0c27ee3a03f60d4845413e6163db996c","name":"administraci\u00f3n","image":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/01a869e9508babcb1c66b6b41356b4ef63d5326e5b27c38b27ed4a46b8e36b9f?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/lpfch.org\/wp"],"url":"http:\/\/lpfch.org\/es\/impact-stories\/author\/admin\/"}]}},"_links":{"self":[{"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/posts\/3878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/comments?post=3878"}],"version-history":[{"count":2,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/posts\/3878\/revisions"}],"predecessor-version":[{"id":15697,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/posts\/3878\/revisions\/15697"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/media\/14826"}],"wp:attachment":[{"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/media?parent=3878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/lpfch.org\/es\/wp-json\/wp\/v2\/categories?post=3878"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}